Cargando…

Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) have changed the landscape of cancer treatment and are emerging as promising curative treatments in different type of cancers. However, only a small proportion of patients have benefited from ICIs and there is an urgent need to find robust biomarkers for individua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaoying, Yang, Yueyao, Huang, Qian, Deng, Yu, Guo, Fukun, Wang, Gang, Liu, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529050/ https://www.ncbi.nlm.nih.gov/pubmed/34692696 http://dx.doi.org/10.3389/fcell.2021.738373

Ejemplares similares

A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
por: Huang, Qian, et al.
Publicado: (2020)

Deciphering Innate Immune Cell-Tumor Microenvironment Crosstalk at a Single-Cell Level
por: Sugimura, Ryohichi, et al.
Publicado: (2022)

Editorial: The self-renewal and reprogramming of cancer stem cells and their crosstalk with the immune microenvironment
por: Li, Chong, et al.
Publicado: (2022)

Exosomal Non-coding RNAs-Mediated Crosstalk in the Tumor Microenvironment
por: Chen, Qi, et al.
Publicado: (2021)

The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
por: Sun, Yueqin, et al.
Publicado: (2021)

Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy
por: Liu, Yini, et al.
Publicado: (2021)

TLRs as a Promise Target Along With Immune Checkpoint Against Gastric Cancer
por: Cui, Lin, et al.
Publicado: (2021)

The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade
por: Cui, Yingnan, et al.
Publicado: (2023)

Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma
por: Zhang, Shichao, et al.
Publicado: (2022)

BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer
por: Cen, Shuyi, et al.
Publicado: (2021)

Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment
por: Song, Yuxuan, et al.
Publicado: (2022)

Editorial: Immune modulation in tumor microenvironment: New perspectives for cancer immunotherapy
por: Deng, Zimu, et al.
Publicado: (2023)

Mesenchymal Stem Cell-Macrophage Crosstalk and Maintenance of Inflammatory Microenvironment Homeostasis
por: Lu, Di, et al.
Publicado: (2021)

Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
por: Deng, Jingjing, et al.
Publicado: (2022)

The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022)

Immune-epigenetic crosstalk in haematological malignancies
por: Wong, Hera, et al.
Publicado: (2023)

Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors
por: Cassetta, Luca, et al.
Publicado: (2018)

Identification of lipid metabolism-associated genes as prognostic biomarkers based on the immune microenvironment in hepatocellular carcinoma
por: Gu, Xiangqian, et al.
Publicado: (2022)

Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer
por: Gu, Yuyang, et al.
Publicado: (2021)

Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target
por: Mai, Shaoshan, et al.
Publicado: (2021)

Editorial: Tumor microenvironment (TME) and tumor immune microenvironment (TIME): New perspectives for prognosis and therapy
por: Ramos, Rodrigo Nalio, et al.
Publicado: (2022)

The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer
por: Xie, Deqian, et al.
Publicado: (2023)

Immune Characteristics of LYN in Tumor Microenvironment of Gliomas
por: Jiang, Chonghua, et al.
Publicado: (2022)

Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
por: Bhattacharjee, Oindrila, et al.
Publicado: (2019)

Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors
por: Ding, Zuoyou, et al.
Publicado: (2021)

Crosstalk between the CBM complex/NF-κB and MAPK/P27 signaling pathways of regulatory T cells contributes to the tumor microenvironment
por: Qi, Tongbing, et al.
Publicado: (2022)

Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated With Remodeling in Cervical Cancer Tumor Microenvironment
por: Xu, Fangfang, et al.
Publicado: (2021)

Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes
por: Shen, Xiaoyan, et al.
Publicado: (2022)

A Systematic Review of the Mechanisms Involved in Immune Checkpoint Inhibitors Cardiotoxicity and Challenges to Improve Clinical Safety
por: Rubio-Infante, Nestor, et al.
Publicado: (2022)

A Novel DNA Repair Gene Signature for Immune Checkpoint Inhibitor-Based Therapy in Gastric Cancer
por: Yuan, Binbin, et al.
Publicado: (2022)

Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration
por: Shih, Ming-Lang, et al.
Publicado: (2022)

The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer
por: Liu, Xiangzheng, et al.
Publicado: (2021)

The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal Adenocarcinoma
por: Liu, Xuefei, et al.
Publicado: (2022)

A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma
por: Cai, Yonghua, et al.
Publicado: (2022)

OAS3 is a Co-Immune Biomarker Associated With Tumour Microenvironment, Disease Staging, Prognosis, and Treatment Response in Multiple Cancer Types
por: Li, Xin-yu, et al.
Publicado: (2022)

Non-immune Cell Components in the Gastrointestinal Tumor Microenvironment Influencing Tumor Immunotherapy
por: Li, Zhengshuo, et al.
Publicado: (2021)

Molecular Crosstalk Between MYC and HIF in Cancer
por: Li, Yanping, et al.
Publicado: (2020)

Ferroptosis Patterns and Tumor Microenvironment Infiltration Characterization in Bladder Cancer
por: Xia, Qi-Dong, et al.
Publicado: (2022)

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
por: Hao, Xiaopei, et al.
Publicado: (2021)

Immune-Related LncRNAs Affect the Prognosis of Osteosarcoma, Which Are Related to the Tumor Immune Microenvironment
por: Huang, Qingshan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3hc3gnnnueqgsv66rr9bdrrh4h